Articles published by TransCode Therapeutics, Inc.
Via GlobeNewswire
Tickers
RNAZ
Via GlobeNewswire
Tickers
RNAZ
Via GlobeNewswire
Tickers
RNAZ
TransCode Therapeutics Announces IRB Approval for FDA Cleared First-In-Human Clinical Trial
April 27, 2023
Via GlobeNewswire
Tickers
RNAZ
Via GlobeNewswire
Tickers
RNAZ
Via GlobeNewswire
Tickers
RNAZ
Via GlobeNewswire
Tickers
RNAZ
TransCode Therapeutics Announces FDA Authorization to Proceed with First-In-Human Clinical Trial
December 29, 2022
Via GlobeNewswire
Tickers
RNAZ
TransCode Therapeutics Announces Withdrawal of Registration Statement
December 06, 2022
Via GlobeNewswire
Tickers
RNAZ
TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update
November 14, 2022
Via GlobeNewswire
Tickers
RNAZ
TransCode Therapeutics to Present at Sidoti Virtual Investor Conference
November 07, 2022
Via GlobeNewswire
Tickers
RNAZ
TransCode Therapeutics Announces Publication of Feline Case Study in Frontiers in Oncology
October 13, 2022
Via GlobeNewswire
Tickers
RNAZ
TransCode Therapeutics Reports Business Progress and Third Quarter 2021 Financial Results
November 15, 2021
Via Business Wire
Tickers
RNAZ
TransCode Therapeutics Appoints Zdravka Medarova, Ph.D., as Chief Technology Officer
September 30, 2021
Via Business Wire
Tickers
RNAZ
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.